We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fusion proteins development strategies and their role as cancer therapeutic agents.
- Authors
Aslam, Shakira; Zulfiqar, Faisal; Hameed, Warda; Qureshi, Shahnila; Zaroon; Bashir, Hamid
- Abstract
Cancer continues to be leading cause of morbidity and mortality despite decades of research and advancement in chemotherapy. Most tumors can be reduced via standard oncology treatments, such as chemotherapy, radiotherapy, and surgical resection, and they frequently recur. Significant progress has been made since targeted cancer therapy inception in creation of medications that exhibit improved tumor‐selective action. Particularly in preclinical and clinical investigations, fusion proteins have shown strong activity and improved treatment outcomes for a number of human cancers. Synergistically combining many proteins into one complex allows the creation of synthetic fusion proteins with enhanced characteristics or new capabilities. Signal transduction pathways are important for onset, development, and spread of cancer. As result, signaling molecules are desirable targets for cancer therapies, and significant effort has been made into developing fusion proteins that would act as inhibitors of these pathways. A wide range of biotechnological and medicinal applications are made possible by fusion of protein domains that improves bioactivities or creates new functional combinations. Such proteins may function as immune effectors cell recruiters to tumors or as decoy receptors for various ligands. In this review article, we have outlined the standard methods for creating fusion proteins and covered the applications of fusion proteins in treatment of cancer. This article also highlights the role of fusion proteins in targeting the signaling pathways involved in cancer for effective treatment.
- Subjects
CHIMERIC proteins; SYNTHETIC proteins; PROTEIN domains; METASTASIS; CANCER treatment
- Publication
Biotechnology & Applied Biochemistry, 2024, Vol 71, Issue 1, p81
- ISSN
0885-4513
- Publication type
Article
- DOI
10.1002/bab.2523